X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Needle-Free Drug Delivery Devices Companies

This report lists the top Needle-Free Drug Delivery Devices companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Needle-Free Drug Delivery Devices industry.

Home Market Analysis Healthcare Research Device Drug Combination Research Drug Filled Devices Research Drug Filled Devices Without Needle Research Needle-Free Drug Delivery Devices Market Companies

Needle-Free Drug Delivery Devices Top Companies

  1. PharmaJet

  2. 3M

  3. MannKind Corporation

  4. Mika Medical Co.

  5. Halozyme, Inc. (Antares Pharma)

*Disclaimer: Top companies sorted in no particular order

Needle-Free Drug Delivery Devices Market Major Players

Needle-Free Drug Delivery Devices Market Concentration

Needle-Free Drug Delivery Devices Market Concentration

Needle-Free Drug Delivery Devices Company List

                            • Halozyme, Inc. (Antares Pharma)

                            • 3M

                            • PharmaJet

                            • Mika Medical Co.

                            • MannKind Corporation

                            • PenJet Corporation

                            • Crossject

                            • Akra Dermojet

                            • Zydus Group

                            • Zealand Pharma A/S

                            • Ferring B.V.


                        Specific to Needle-Free Drug Delivery Devices Market
                        Need More Details On Market Players And Competitors?
                        Download Sample

                        Needle-Free Drug Delivery Devices Market Report Snapshots

                        Needle-Free Drug Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)